Introduction {#Sec1}
============

An abdominoperineal excision of the rectum (APER) may be required for patients with a rectal cancer less than 6 cm from the anal verge, where an anterior resection with anastomosis is not possible \[[@CR1]\]. Concern over coning of the specimen with standard perineal dissection, leading to perforation and circumferential resection margin (CRM) involvement \[[@CR2]--[@CR6]\] with poorer oncological outcomes compared to a low anterior resection \[[@CR7]\] led to the widespread adoption of extra-levator abdominoperineal excision of rectum (ELAPER).

The ELAPER technique, based upon the original description of APER by Miles \[[@CR8]\], involves excision of a wide area of tissue around the rectal tumour, and division of the levators at their origin, producing a cylinder of tissue and avoiding wasting seen with standard technique \[[@CR9]\]. This larger cylindrical specimen improves oncological outcome but leaves a large pelvic floor defect requiring reconstruction to avoid perineal herniation \[[@CR10]\]. Wound complications are also increased by impaired healing associated with neoadjuvant radiotherapy to the low rectum used in the majority of these patients \[[@CR11]--[@CR13]\].

Several methods have been suggested for closure of the perineal defect, including primary closure (with \[[@CR14]\] or without omentoplasty, \[[@CR15]\]), myocutaneous flaps \[[@CR11]\] and mesh repairs \[[@CR16]\]. So far there is no clear consensus on the optimal method, with a lack of long-term follow-up data in this patient group \[[@CR17]\]. Primary closure has been shown to increase wound tension and the potential for a postoperative collection due to the large amount of dead space left in the pelvis \[[@CR13]\]. Myocutaneous flaps and biological mesh are currently recommended by specialty associations \[[@CR17]\]. Flaps have been associated with higher costs, longer operating time, donor-site morbidity and the need to have an experienced plastic surgeon available \[[@CR16]\]. We have previously shown that biological mesh reconstruction, first described by our group \[[@CR18]\] is a safe and cost-effective method of perineal wound closure \[[@CR16], [@CR19]\].

Rates of perineal herniation (PH) vary widely in the current literature, occurring after primary closure, mesh and myocutaneous flap reconstruction \[[@CR20]--[@CR23]\]. It has been reported that the majority of perineal hernias occur in the first year postoperatively \[[@CR21], [@CR24], [@CR25]\] but longer term follow-up is lacking.

The aim of this study was to evaluate long-term outcome data following a biological mesh pelvic floor reconstruction in a large cohort.

Materials and methods {#Sec2}
=====================

All patients having an ELAPER for low rectal cancer or a salvage procedure for anal cancer with biological mesh reconstruction were identified using a prospectively maintained colorectal multidisciplinary team database. This study adds additional cases and provides long-term follow-up to our earlier case series \[[@CR19]\]. Any patient with disease extending beyond or involving the mesorectal fascia received neoadjuvant long course chemoradiotherapy (LCCRT) using 45 Gy in 25 fractions with twice daily capecitabine.

Intraoperative technique involved rectal dissection distally in the total mesorectal excision plane, until the mesorectum thins, before repositioning the patient into the prone jack-knife position and completing the extra-levator excision as previously described \[[@CR16]\]. The perineal defect is then closed using biological mesh (Surgisis^®^, Biodesign™, Cook Medical, Bloomington, IN, USA), which is sutured laterally to the origins of the divided levators. There was no routine postoperative use of antibiotics or drains and the patients were allowed to mobilise immediately after surgery. Prolonged sitting was discouraged. Postoperatively, patients were followed up in a specialist-nurse led clinic 4 weeks after surgery, with 6-monthly appointments for 2 years and computed tomography (CT) scans of the chest, abdomen and pelvis at 1 and 2 years. A colonoscopy was also performed at 1 and 5 years. Some patients received longer follow-up due to individual circumstances related to either their perineal wound or progression of their disease.

Electronic case notes, clinic letters and cross-sectional imaging were reviewed to identify wound complications or symptoms of perineal herniation. Further review of cross-sectional imaging was performed to identify any evidence of perineal herniation. Perineal herniation was defined as the presence of intra-abdominal content beyond a line between the coccyx and the lower margin of the pubic symphysis on sagittal views.

Complications were defined as either early (≤ 30 days postoperatively) or late (\> 30 days post-operatively) and graded according to the Clavien--Dindo classification \[[@CR26]\]. A major complication was defined as Grade III or above of this classification system.

Descriptive data are presented as median (IQR) or *n* (%) as appropriate. No statistical analysis was performed for this descriptive study.

Results {#Sec3}
=======

One hundred consecutive patients had biological mesh pelvic floor reconstruction after ELAPER between February 2008 and June 2018. The median age was 66.7 years (59--72). Seventy (70%) of the patients were male.

Demographics and preoperative staging are shown in Table [1](#Tab1){ref-type="table"}, along with details of neoadjuvant treatment. The majority of patients (*n* = 70) had neoadjuvant long course chemoradiotherapy. One patient had a shortened course of chemotherapy due to side-effects.Table 1Patient demographics and preoperative dataDemographicNumber of patients *N* (%)*Sex*Male70 (70%)Female30 (30%)Median age (range)66.7 (39--83)*ASA grade*132 (32%)253 (53%)314 (14%)41 (1%)*Preoperative staging*T-stage T14 (4.1%) T227 (27.8%) T353 (54.6%) T413 (13.4%)Nodal status N041 (42.3%) N136 (37.1%) N220 (20.6%)Metastases M093 (95.9%) M14 (4.1%)Neoadjuvant therapy Long-course chemoradiotherapy70 (70%) Long-course radiotherapy1 (1%)None29 (29%)*Tumour location*Median distance from anal verge2 cmRange0--6 cm

Histopathological findings are shown in Table [2](#Tab2){ref-type="table"}, along with the details of any postoperative adjuvant chemotherapy received. Laparoscopic assistance during the abdominal phase of the procedure was used in 5 cases, with a further 4 cases using robotic assistance. The remaining cases were performed using the standard ELAPER technique as described previously \[[@CR13]\]. There were 3 tumour perforations and 6 positive circumferential resection margins (CRM) in the 100 patients. Six patients had a local recurrence.Table 2Histopathological dataHistopathological dataNumber of patients, *N* (%)Adenocarcinoma85 (85%)SCC4 (4%)Melanoma3 (3%)*Staging*Complete response12 (12%) T1N011 (11%) T1N11 (1%) T2N024 (24%) T2N16 (6%) T2N22 (2%) T3N025 (25%) T3N110 (10%) T3N26 (6%) T4N01 (1%) T4N11 (1%) T4N21 (1%)*Differentiation*Well8 (8%)Moderate73 (73%)Poor4 (4%)N/A15 (15%)*Lympho/vascular involvement*Yes35 (35%)No65 (65%)*CRM*Positive6 (6%)Negative82 (82%)N/A12 (12%)*Tumour perforation*Yes3 (3%)No97 (97%)*Post-operative therapy*Chemotherapy29 (29%)Chemoradiotherapy4 (4%)Lung resection4 (4%)Liver resection5 (5%)*SCC* squamous cell carcinoma

The median length of follow-up from time of operation was 4.9 (2.3--6.7) years with a median of 2.1 (1.3--2.8) years in which patients were seen in clinic. There was no death by 30 days and 1-, 2- and 5-year mortality was 3, 8 and 12%, respectively. Cumulative mortality was 22%, with only 1 patient dying from causes unrelated to rectal cancer.

Perineal herniation {#Sec4}
-------------------

One patient developed a symptomatic perineal hernia, presenting with a painful palpable perineal lump that required elective surgical repair. This hernia was confirmed on CT at 379 days following ELAPER.

This perineal hernia was repaired with the patient in the jack-knife prone position. The perineal scar was reopened and the sac carefully dissected down to the pelvic sidewall at the level of the levator attachments. The sac was bivalved and one leaf edge sutured to the opposite pelvic side-wall. A new mesh was fixed to the pelvic sidewall laterally and posteriorly, and the remaining sac secured to the opposite side wall, sandwiching the mesh between the two.

A further 7 asymptomatic perineal hernias, not detectable on clinical examination, were discovered radiologically on retrospective review of CT images. Only 1 of these 7 hernias was mentioned in the original CT report. Figure [1](#Fig1){ref-type="fig"} displays a Kaplan--Meier curve of both radiologically detected and symptomatic perineal herniae. At 4 years the cumulative radiologically detected perineal hernia rate was 8%.Fig. 1Kaplan--Meier curve of radiologically detected and symptomatic perineal herniae

Other complications {#Sec5}
-------------------

No other complications were directly attributable to the biological mesh and no mesh needed to be removed. Table [3](#Tab3){ref-type="table"} describes the wound complications, which occurred in 33/100 patients. There were only 7 (7%) major wound complications. Table 3Wound ComplicationsWound complicationNumber of patients, *N* (%)Clavien--Dindo classificationDelayed wound healing33 (33%)ISimple discharge requiring dressing8 (8%)ISinus formation5 (5%)IPartial dehiscence4 (4%)ISuperficial wound infection requiring antibiotics9 (9%)IIDehiscence requiring EUA3 (3%)IIIbCollection/abscess requiring VAC4 (4%)IIIb*EUA* examination under anaesthesia, *VAC* vacuum assisted closure

The most common complication unrelated to the perineal wound was parastomal hernia, which was seen in 17/100 patients (Table [4](#Tab4){ref-type="table"}). One of these parastomal hernias required repair. Eight patients continue to suffer from chronic perineal pain; which has been extensively investigated in each with no cause identified. There was no postoperative death as a result of complications.Table 4Other complicationsType of complicationNumber of patientsClavien--Dindo classification*Early*Hospital acquired pneumonia2 (2%)IIIleus2 (2%) (1 required TPN)IISmall bowel obstruction3 (3%)IIPulmonary embolism1 (1%)II*Late*Parastomal hernia17 (17%)IChronic perineal pain8 (8%)IChronic back pain1 (1%)IIncisional hernia2 (2%)IPerineal hernia7 (7%)IDeep vein thrombosis1 (1%)IIUrinary incontinence1 (1%)IIParastomal hernia requiring repair1 (1%)IIIbPerineal hernia requiring repair1 (1%)IIIb*TPN* total parenteral nutrition

Discussion {#Sec6}
==========

This is the largest series of biological mesh perineal reconstruction following ELAPER. This study shows biological mesh repair is an effective and safe method for the perineal reconstruction following ELAPER, with no mesh related early complications and a very low long-term herniation rate.

One of the main challenges to closing the perineal wound after ELAPER is the impairment of healing as a consequence of preoperative long course chemoradiotherapy, which doubles the rate of perineal wound complications in ELAPER \[[@CR12], [@CR27]\], probably due to impaired tissue oxygenation, decreased fibroblast production of collagen and altered cellular response \[[@CR13]\]. Perineal wound infection rates have been reported to be as high as 37% following mesh repair \[[@CR28]\]. Our study showed 33% of patients had a wound that was not completely healed at 1 month, consistent with the current literature, which reports delayed healing rates of up to 42% \[[@CR23], [@CR29]--[@CR32]\]. Due to the position of insertion; the biological mesh rarely becomes involved in a superficial wound infection, and as such removal of the mesh is highly unlikely to be required \[[@CR20], [@CR28]\]. Seven patients had a wound dehiscence that required examination under anaesthesia (EUA), with 4 of these needing vacuum-assisted closure (VAC).

Wide variation in perineal hernia rates is reported in the literature. A recent systematic review reports rates of 0--26%, with variable lengths of follow-up \[[@CR24]\]. In addition, there is currently no standard definition of a perineal hernia following ELAPER. There may be underreporting of asymptomatic perineal hernias on CT, as demonstrated in this study, because the scan is performed as part of surveillance rather than specifically focusing on the level of the pelvic floor \[[@CR25]\]. Of the 8 hernias that were identified, just 2 were mentioned in the standard report and the remaining 6 identified only retrospectively as part of this study. Whether radiologically detected hernias progress to symptomatic hernias requiring treatment is unknown.

Most perineal hernias are thought to occur within the first 1--2 years after surgery, and this is supported by our findings \[[@CR28], [@CR31]\]. The biological mesh used is an acellular matrix biomaterial produced from porcine small intestine mucosa. It encourages the proliferation and the formation of fibroblasts in the wound, without triggering the body's natural response to a foreign body \[[@CR33]\]. Once inserted it is quickly incorporated, resulting in strong vascularised tissues \[[@CR34]\]. Although Surgisis^®^ is not a cross-linked mesh \[[@CR35]\], raising concerns regarding the use of this mesh in high-tension areas \[[@CR36]\], the current study has shown it provides adequate support in 92% of patients.

Other methods have been proposed aiming to reduce the incidence of perineal hernia. Recently, Blok et al. described the use of omentoplasty \[[@CR15]\]. However, this showed no decrease in the pelvic or perineal morbidity and increased the risk of reoperation in those having omentoplasty. Bulut et al. proposed a technique of using a large filled catheter balloon in the pelvic cavity with the intention of forming a thin fibrotic peritoneal layer \[[@CR37]\]. No perineal hernias were detected by 3 years in a small cohort of 15 patients \[[@CR37]\].

The most frequently used alternatives to mesh repair are myocutaneous flaps \[[@CR17]\]. Flaps provide support in a high tension area, also with the aim of importing non-irradiated tissue to aid healing \[[@CR13]\]. A systematic review did not identify any difference in perineal wound complications and hernias between mesh and myocutaneous flaps \[[@CR17], [@CR38]\]. However, Christensen et al. did find a large difference in perineal hernia rates between fasciocutaneous flaps (21%) and mesh reconstruction (0%) \[[@CR21]\]. There are significant financial costs associated with myocutaneous flap compared to biological mesh reconstruction that need to be considered, primarily due to the increased operative costs and length of hospital stay \[[@CR16]\]. Patients are also not required to be on their side lying down for 6 weeks if a mesh reconstruction is performed.

A wide variation in wound healing and perineal hernia rates is also reported after primary closure of the perineum \[[@CR17]\]. Primary closure is associated with high tension and a large volume area of dead space, which predisposes to postoperative perineal complications \[[@CR39]\]. The only RCT comparing primary closure with biological mesh reconstruction, showed no significant difference in wound healing, but a large difference in perineal hernia rates. The clinically detectable perineal hernia rate was 27% in the primary closure group compared with 13% in the biological mesh group (*p* = 0.0316) \[[@CR14]\]. Sayers et al. reported 5-year outcomes following ELAPER and showed a 26% perineal hernia rate \[[@CR25]\]. In primary closure, they also reported a mean time to perineal hernia of 10.5 months \[[@CR25]\].

Conclusions {#Sec7}
===========

Biological mesh is both a safe and effective long-term method for perineal reconstruction after extralevator abdominoperineal excision of the rectum, and is associated with a very low rate of perineal herniation.
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